LETTER
Cost-effectiveness of Prostate Cancer Screening and Treatment
David L. Hahn
15 November 1993 | Volume 119 Issue 10 | Pages 1054-1055
TO THE EDITOR:
My Swedish brother-in-law, who has lived and worked in the United States for more than two decades, observes that often Americans act first and analyze later. This tendency is manifest in aggressive recommendations for unproven yet demonstrably morbid screening programs such as those for asymptomatic prostate cancer.
Garnick [1] documents that screening for asymptomatic prostate cancer is unproven and that consensus groups in Sweden, France, Canada, and the United States, as well as the International Union Against Cancer, do not recommend it. Nevertheless, he devotes considerable space to a detailed description of unproven screening procedures recommended by the American Cancer Society and concludes that "a greater effort must be made to promote earlier diagnosis of prostate cancer".
It is time that American physicians recognize what physicians in the rest of the developed world already know: Advocates of screening procedures of unproven benefit but known harm would replace the traditional ethical precept of "primum non nocere" (first, do no harm) with its opposite, "primum facere" (first, do something).
1. Garnick MB. Prostate cancer: screening, diagnosis and management. Ann Intern Med. 1993; 118:804-18.
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
Include no more than 300 words of text, three authors, and five references
Type with double-spacing
Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.